USPTO Deadlines
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 23, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 23, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 28, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 27, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 21, 2010 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 26, 2010 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Oct 26, 2010 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Oct 26, 2010 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| May 21, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 20, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 21, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 19, 2010 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| May 19, 2010 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| May 19, 2010 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Mar 3, 2010 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Mar 2, 2010 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 21, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 1, 2010 | PGEX | O | PETITION GRANTED - EXTENSION REQUEST FILED | Loading... |
| Feb 3, 2010 | PINM | O | INCOMPLETE PETITION NOTICE MAILED | Loading... |
| Feb 2, 2010 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Dec 1, 2009 | PETR | I | PETITION TO REVIVE-RECEIVED | Loading... |
| Feb 1, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 1, 2009 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Dec 1, 2009 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Dec 1, 2009 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Nov 23, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 23, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 21, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 27, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 7, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 22, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 16, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 15, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 15, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 15, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 1, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 2, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 2, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 2, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 27, 2008 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Feb 26, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Preparation for the relief of pain
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
GLEN MARK THERAPEUTICS
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"